cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1988; 11:359-364
© 1988 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olshansky, B
Right arrow Articles by Waldo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olshansky, B
Right arrow Articles by Waldo, A.

Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm

B Olshansky, K Okumura, PG Hess, RW Henthorn, and AL Waldo

Department of Medicine, Case Western Reserve University, University Hospitals of Cleveland, Ohio 44106.

Rapid atrial pacing is a useful technique and often the therapy of choice to terminate atrial flutter in patients. However, interruption of atrial flutter by rapid atrial pacing may not always produce sinus rhythm, but rather may result in atrial fibrillation. Twelve patients with spontaneous atrial flutter that had been present for greater than 24 h were studied to assess the efficacy of atrial pacing, alone and in combination with procainamide, to convert atrial flutter to normal sinus rhythm. Rapid atrial pacing for greater than or equal to 15 s from selected atrial sites at selected pacing rates were performed during atrial flutter. The initial pacing rate was always at a cycle length 10 ms shorter than the atrial flutter cycle length. If atrial flutter persisted after cessation of pacing, it was repeated at progressively shorter cycle lengths until either a rate of 400 beats/min was achieved or atrial fibrillation was induced. In two patients, atrial flutter was converted to sinus rhythm with pacing alone. Three patients developed sustained atrial fibrillation as a result of the rapid atrial pacing, this rhythm ultimately reverting back to atrial flutter in two. Ten patients received procainamide and 9 of the 10 had lengthening of the atrial flutter cycle length by a mean of 68 ms (1 patient continued to have atrial fibrillation). Then, using the same atrial pacing protocol, high right atrial pacing alone at a mean cycle length of 227 ms interrupted atrial flutter in all these patients, returning their rhythm to sinus rhythm. It is concluded that intravenous procainamide effectively augments the efficacy of rapid atrial pacing to convert atrial flutter to sinus rhythm.


This article has been cited by other articles:


Home page
EuropaceHome page
M. Gulizia, S. Mangiameli, S. Orazi, G. Chiaranda, G. Boriani, G. Piccione, N. DiGiovanni, A. Colletti, C. Puntrello, G. Butera, et al.
Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device
Europace, July 1, 2006; 8(7): 465 - 473.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Roy, B. H. Rowe, I. G. Stiell, B. Coutu, J. H. Ip, D. Phaneuf, J. Lee, H. Vidaillet, G. Dickinson, S. Grant, et al.
A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation
J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2355 - 2361.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. H. Everett IV, J. G. Akar, L.-C. Kok, J. R. Moorman, and D. E. Haines
Use of global atrial fibrillation organization to optimize the success of burst pace termination
J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1831 - 1840.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Disertori, L. Padeletti, M. Santini, P. Dini, M. Gasparini, G. Inama, M. Botto, G. Boriani, A. Capucci, R. Ricci, et al.
Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: the AT500 Italian Registry
Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P16 - P24.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
C. W. Israel, J. R. Ehrlich, G. Gronefeld, A. Klesius, T. Lawo, B. Lemke, and S. H. Hohnloser
Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device
J. Am. Coll. Cardiol., August 1, 2001; 38(2): 355 - 363.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
F. Doni, M. Manfredi, C. Piemonti, E. Staffiere, S. Todd, A. Rimondini, and C. Fiorentini
New onset atrial flutter termination by overdrive transoesophageal pacing: effects of different protocols of stimulation
Europace, January 1, 2000; 2(4): 292 - 296.
[Abstract] [PDF]


Home page
CirculationHome page
B. S. Stambler, M. A. Wood, K. A. Ellenbogen, K. T. Perry, L. K. Wakefield, and J. T. VanderLugt
Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation
Circulation, October 1, 1996; 94(7): 1613 - 1621.
[Abstract] [Full Text]



 
  cardiology careers collections past issues search home